| Phrase | Consultant | Town | Special Interests |
| medical microbiology | *Consultant(s)* | *Towns* | Antimicrobial resistance, infection outcomes research, antimicrobial pharmacokinetics and dynamics, antibacterial drug development, medical microbiology |
| Microbiology | *Consultant(s)* | *Towns* | Virology |
| Microbiology | *Consultant(s)* | *Towns* | Infectious disease, sepsis |
| Microbiology | *Consultant(s)* | *Towns* | Virology, faecal transplant |
| Microbiology | *Consultant(s)* | *Towns* | Vaccination, immunisation, infection control |
| Microbiology | *Consultant(s)* | *Towns* | Infectious diseases, genito-urinary medicine, HIV |
| Microbiology | *Consultant(s)* | *Towns* | Virology |
| Microbiology | *Consultant(s)* | *Towns* | Bacterial infection, healthcare associated infection, antibiotic resistance in hospitals, C difficile, helicobacter pylori, managing Carbapenemase resistance in hospitals, antimicrobial stewardship |
| Microbiology | *Consultant(s)* | *Towns* | Virology |
| Microbiology | *Consultant(s)* | *Towns* | Infection control and prevention, infection diagnostics, infection management |
| Microbiology | *Consultant(s)* | *Towns* | Infection control |
| Microbiology | *Consultant(s)* | *Towns* | Infectious diseases |
| Microbiology | *Consultant(s)* | *Towns* | Virology |
| Microbiology | *Consultant(s)* | *Towns* | Infection prevention and control |
| Microbiology | *Consultant(s)* | *Towns* | TB - tuberculosis, mycobacterial diseases, antimicrobial drug resistance, pathogenesis of diseases |
| Microbiology | *Consultant(s)* | *Towns* | Virology |
| Microbiology | *Consultant(s)* | *Towns* | Infection control, virology |
| Microbiology | *Consultant(s)* | *Towns* | Management of infection in the diabetic foot |
| Microbiology | *Consultant(s)* | *Towns* | Infection control |
| Microbiology | *Consultant(s)* | *Towns* | Infection control, management of clostridium difficile, MRSA, community acquired pneumonia, antibiotic therapy in adult respiratory disease |
| Microbiology | *Consultant(s)* | *Towns* | Infection control and prevention |
| Microbiology | *Consultant(s)* | *Towns* | Acute infection control |
| Microbiology | *Consultant(s)* | *Towns* | Infectious disease epidemiology |
| Microbiology | *Consultant(s)* | *Towns* | Tropical medicine, urinary tract infections, sexually transmitted infections |
| microbiology | *Consultant(s)* | *Towns* | COVID-19, microbiology |
| Microbiology | *Consultant(s)* | *Towns* | Sperm storage for those undergoing radiotherapy or chemotherapy |
| Microbiology | *Consultant(s)* | *Towns* | Virology, antimicrobial stewardship |
| Microbiology | *Consultant(s)* | *Towns* | Virology |
| Microbiology | *Consultant(s)* | *Towns* | Antimicrobial stewardship |
| Microbiology | *Consultant(s)* | *Towns* | Microbiology |
| Microbiology | *Consultant(s)* | *Towns* | Healthcare acquired infection |
| Microbiology | *Consultant(s)* | *Towns* | Necrotising fasciitis, gangrene, streptococcal infections, zoonotic diseases, animal bites, PVL-SA - Panton-Valentine leukocidin staphylococcus aureus, skin and soft tissue infections |
| Microbiology | *Consultant(s)* | *Towns* | Genito-urinary medicine |
| Microbiology | *Consultant(s)* | *Towns* | Prevention and control of hospital acquired infections, pulsed faecal microbiota transplantation for recalcitrant recurrent Clostridium difficile |
| Microbiology | *Consultant(s)* | *Towns* | Infection prevention and control, virology |
| Microbiology | *Consultant(s)* | *Towns* | Infection prevention and control, CBRN - chemical, biological, radiological, nuclear clinical management & health protection |
| Microbiology | *Consultant(s)* | *Towns* | Antimicrobial chemotherapy, infection control and prevention |
| Microbiology | *Consultant(s)* | *Towns* | Virology, sepsis, blood stream infections, neonatal infection, invasive staphylococcal disease |
| Microbiology | *Consultant(s)* | *Towns* | Infection prevention and control |
| Microbiology | *Consultant(s)* | *Towns* | Infection control |
